Hu, S., Liang, S., Guo, H., Zhang, D., Li, H., Wang, X., . . . Lou, Z. (2014). Comparison of the inhibition mechanisms of Adalimumab and Infliximab in treating tumor necrosis factor α-associated diseases from a molecular view. American Society for Biochemistry and Molecular Biology.
Chicago Style CitationHu, Shi, et al. Comparison of the Inhibition Mechanisms of Adalimumab and Infliximab in Treating Tumor Necrosis Factor α-associated Diseases From a Molecular View. American Society for Biochemistry and Molecular Biology, 2014.
Cita MLAHu, Shi, et al. Comparison of the Inhibition Mechanisms of Adalimumab and Infliximab in Treating Tumor Necrosis Factor α-associated Diseases From a Molecular View. American Society for Biochemistry and Molecular Biology, 2014.